Blood Glucose Determinations in Large for Gestational Age Infants

Howe, Robert S. Van; Storms, Michelle R.

doi:10.1055/s-2008-1076602

Cited by 9 publications

(3 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Even more interesting is the observation that babies between the 90th and 95th percentiles appear to have different glucose responses following birth when compared with their larger counterparts (greater than the 95th percentile). There is some debate regarding the need to screen LGA babies (15)(16)(17). Our results fuel this debate.…”

Section: Clinical Reviewsupporting

confidence: 62%

Two hour blood glucose levels in at-risk babies: An audit of Canadian guidelines

Croke

Sullivan

Ryan-Drover

et al. 2009

Paediatrics &Amp; Child Health

View full text Add to dashboard Cite

show abstract

Section: Clinical Reviewsupporting

confidence: 62%

Two hour blood glucose levels in at-risk babies: An audit of Canadian guidelines

Croke

Sullivan

Ryan-Drover

et al. 2009

Paediatrics &Amp; Child Health

View full text Add to dashboard Cite

show abstract

“…27 Maternal and infant categories at increased risk for hypoglycemia are listed in Table 2. [47][48][49] Large for gestational age infants born to screened nondiabetic mothers appear not at risk of hypoglycemia 50 nor at increased risk of poor psychomotor development at 4 years of age. 51 Umbilical cord blood glucose does not seem to predict early hypoglycemia.…”

Section: Risk Factors For Hypoglycemiamentioning

confidence: 99%

ABM Clinical Protocol #1: Guidelines for Glucose Monitoring and Treatment of Hypoglycemia in Term and Late Preterm Neonates, Revised 2021

Wight

Stehel²,

Noble³

et al. 2021

Breastfeeding Medicine

View full text Add to dashboard Cite

A central goal of The Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical conditions that may impact breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient. PurposeT o provide guidance in the first hours/days of life to: Differentiate transitional neonatal hypoglycemia from persistent pathologic hypoglycemia Prevent clinically significant hypoglycemia in newborn infants Appropriately monitor blood/plasma glucose levels in at-risk term and late preterm neonates Manage clinically significant hypoglycemia in newborn infants to prevent neurologic injury Maximize breast milk provision to babies Establish and preserve maternal milk supply during medically necessary supplementation for hypoglycemia or during separation of mother and baby. About the 2020 Revised ProtocolKey research articles before 2014 were retained and more recent information was added from primary studies and compilations. Specific studies were assigned a level of evidence, and Strength of Recommendation Taxonomy (SORT: A, B, C) 1 was used for recommendations. The SORT rating system addresses the three key elements (quality, quantity, and consistency) recommended by the Agency for Healthcare Research and Quality. Levels of evidence are applied after each specific recommendation in brackets, e.g., [A], [B], [C].Recommendations are updated based on the last 6 years of new information and critical older studies. This clinical protocol is intended to provide practitioners with pragmatic evidence-based guidance to keep infants safe while mini-

show abstract

“…This condition is about six fold more frequently found in IDMs than in non-IDMs 17 . Delivery by CS is associated with respiratory distress in term infants as a result of the retained lung field (Transient Tachypnea of the Newborn) 18 .…”

Section: Introductionmentioning

confidence: 99%

Neonatal Outcomes of Large-for-Gestational Age Infants with or without Gestational Diabetes Mellitus

Begum

Chowdhury

et al. 2018

Chatt Maa Shi Hosp Med Coll J

View full text Add to dashboard Cite

Background: Infants are considered Large for Gestational Age (LGA)if their birth weight is greater than the 90th percentile for gestational age. Birth weight is influenced by a number of factors with maternal diabetes being one of the most common risk factor affecting birth weight. They have an increased risk for adverse perinatal outcomes. The aim of the present study was to compare the neonatal outcomes of LGA infants delivered by women with and without gestational diabetes mellitus. Methods: This is a prospective study of all live-born LGA infants of 37 weeks of gestation with a birth weight of 4000g admitted at Neonatal ward of Chattagram Maa Shishu-O-General Hospital (CMSOGH) between 1 st August 2013 to 31 st July 2014. Type of sampling was purposive convenient sampling. A total of 51 neonatal patients were included. Data was collected in case record form. Data collected for the mothers included age, parity, gestational age and mode of delivery. Data for the infants include sex, birth weight, birth length and laboratory test. Outcomes were compared between infants of diabetic mothers (Group A) and infants of non-diabetic mothers (Group B). Then data was analyzed by SPSS 17.0 program and presented by tabular method, diagram and chart. Results: Among fifty one study subjects, thirty were Infants of Diabetic Mothers (IDMs) while twenty one were nonIDMs. 19 (63.3%) of the IDMs were male while 11 (36.7%) were female. Among the 21 non-IDMs 10 (47.6%) were male and 11 (52.4%) were female. Male to female ratio was 1.4:1. 5 (16.7%) of the IDMs were delivered vaginally while 25 (83.3%) were delivered by Caesarian Section (CS) where as 8 (38.1%) of the nonIDMs were delivered vaginally while 13 (61.9%) were delivered by CS. Respiratory distress was the most common morbidity affecting 70% of the IDMs and 66.7% of the non-IDMs. TTN accounted for the majority of the respiratory distress cases, occurring in 17 of the IDMs and 12 of the non-IDMs. Regarding analysis of other clinical features, convulsion (63.3%) was present more in IDMs than in non-IDMs (52.4%) cyanosis was found more in IDMs (60%) than non-IDMs (38.1%). Hypoglycemia was found more in IDMs than in non-IDMs. Mean glucose values were 41.06±19.91mg/dl for IDMs and 53.06±28.96mg/dl for the non-IDMs (p=0.001). Hyperbilirubinemia was more frequently observed in IDMs than in nonIDMs. About 17 (56.6%) of the IDMs and 7(33.3%) of the non-IDMs developed jaundice during the period of hospital stay. Polycythemia was not observed in both the groups but PCV was higher in IDMs (53.96±6.36) compared to non-IDMs (50.50±8.76). Hypocalcemia was not peculiar to a specific group. Five of the IDMs had congenital anomaly, of which three of them had cardiac anomaly. One of the non-IDM was suffering from ventricular septal defect. Birth asphyxia was observed more in non-IDMs (71.4%) than in IDMs (53.3%).One of the IDMs and two of the non-IDMs sustained a brachial plexus injury following vaginal delivery.

show abstract

Blood Glucose Determinations in Large for Gestational Age Infants

Cited by 9 publications

References 21 publications

Two hour blood glucose levels in at-risk babies: An audit of Canadian guidelines

Two hour blood glucose levels in at-risk babies: An audit of Canadian guidelines

ABM Clinical Protocol #1: Guidelines for Glucose Monitoring and Treatment of Hypoglycemia in Term and Late Preterm Neonates, Revised 2021

Neonatal Outcomes of Large-for-Gestational Age Infants with or without Gestational Diabetes Mellitus

Contact Info

Product

Resources

About